- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01807559
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Linda Galow, MS
- Phone Number: 832-434-9730
- Email: linda@sonitusmedical.com
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85004
- Recruiting
- Arizona Ear Center
-
Contact:
- Kelly Hernanadez, AuD
- Phone Number: 602-307-9919
- Email: audiology@arizonaear.com
-
Principal Investigator:
- Mark Syms, MD
-
-
California
-
La Jolla, California, United States, 92037
- Recruiting
- California Hearing and Balance
-
Contact:
- Sara Mattson, AuD
- Phone Number: 858-909-0770
-
Principal Investigator:
- Ritvik Mehta, MD
-
Newport Beach, California, United States, 92663
- Recruiting
- Shohet Ear Associates
-
Contact:
- Cheryl Tanita, AuD
- Phone Number: 949-631-4327
- Email: ctanita@eardoctor.org
-
Principal Investigator:
- Jack Shohet, MD
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20006
- Not yet recruiting
- The George Washington University-Department of Otolaryngology
-
Contact:
- Rachel Lazaro, AuD
- Phone Number: 202-741-3275
- Email: rlazaro@mfa.gwu.edu
-
Principal Investigator:
- Ashkan Monfared, MD
-
-
Florida
-
Tampa, Florida, United States, 33613
- Recruiting
- Physicians Choice Hearing and Balance
-
Contact:
- Jeffrey Clark, AuD
- Phone Number: 813-558-1477
-
Principal Investigator:
- Jeffrey Clark, AuD
-
-
Texas
-
San Antonio, Texas, United States, 78240
- Recruiting
- Ear Medical Group
-
Contact:
- Robyn Shanley, PhD
- Phone Number: 210-614-6070
- Email: RobynS@earmedicalgroup.com
-
Principal Investigator:
- Charles Syms, MD
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- Recruiting
- University Health Science Center (University of Utah Hospital)
-
Principal Investigator:
- Richard Gurgel, MD
-
Contact:
- Diane Tyler, RN
- Phone Number: 801-587-4824
- Email: diane.tyler@hsc.utah.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subjects who previously were enrolled in SoundBite Hearing System Long Term Multi Site Patient Use Study (Protocol CLN006) and completed the 12 month study visit.
Additionally, subjects must meet one of the two criteria for hearing loss:
Moderately severe, severe, or profound sensorineural hearing loss in one ear and normal hearing in the other ear (i.e. single sided deafness or "SSD"). Normal hearing is defined as a pure tone average (PTA) air-conduction (AC) hearing threshold (measured at 0.5, 1, 2, and 3 kHz) of better than or equal to 25 dB HL.
OR
- Conductive hearing loss where the pure tone average bone-conduction hearing threshold (measured at 0.5, 1, 2, and 3 kHz) is better than or equal to 25 dB HL.
Exclusion Criteria:
Subjects that do not meet one of the two the audiometric criteria as measured on the audiogram for the 12 month study appointment for Protocol CLN006:
- A moderately severe, severe, or profound sensorineural hearing loss in one ear and normal hearing in the other ear (i.e. single sided deafness or -SSD‖). Normal hearing is defined as a pure tone average (PTA) air-conduction (AC) hearing threshold (measured at 0.5, 1, 2, and 3 kHz) of better than or equal to 25 dB HL.
Patients with conductive hearing loss where the pure tone average bone-conduction hearing threshold (measured at 0.5, 1, 2, and 3 kHz) is better than or equal to 25 dB HL
- The SoundBite Hearing System and all portions of it are contraindicated for use in an MRI Environment and should be removed prior to MRI exposure
- The SoundBite Hearing System is not to be used in patients with known hypersensitivity to any of the components including allergies to polymers.
- The SoundBite Hearing system is contraindicated for vulnerable populations that are unable to use their hands such as paraplegics or others that are unable to comply with the warnings in the product's labeling.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire
Time Frame: 24 Months
|
Change in Abbreviated Profile of Hearing Aid Benefit (APHAB, Form A- New Formate, Hearing Aid Research Lab, University of Memphis, 1994) score at 24 months compared to baseline.
|
24 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Aided Threshold Testing
Time Frame: 24 Months
|
Aided Threshold testing of the impaired ear at 24 months as compared with baseline using the SoundBite Hearing System
|
24 Months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Single Sided Deafness Questionnaire
Time Frame: 24 Months
|
This questionnaire assesses quality of life outcomes.
|
24 Months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLN009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Conductive Hearing Loss
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalSahlgrenska University Hospital, SwedenCompletedConductive Hearing Loss | Mixed Hearing LossSweden
-
Audioptics Medical IncorporatedNot yet recruitingConductive Hearing Loss, Middle Ear
-
Oticon MedicalActive, not recruitingConductive Hearing Loss | Mixed Hearing LossSweden
-
Oticon MedicalCompletedConductive Hearing Loss | Mixed Hearing Loss | Unilateral Partial DeafnessSweden
-
CochlearCompletedConductive Hearing Loss | Deafness; Sensoneural Single Sided | Mixed Hearing LossUnited States, Netherlands, Australia, Germany, Poland
-
CochlearCompletedConductive Hearing Loss | Deafness; Sensoneural Single Sided | Mixed Hearing LossAustralia
-
Oticon MedicalCompletedConductive Hearing Loss | Unilateral Partial Deafness | Mixed Conductive-sensorineural Hearing LossNetherlands
-
Khon Kaen UniversityPrince of Songkla University; Chiang Mai UniversityNot yet recruitingNormal Hearing | Conductive Hearing Loss, Middle EarThailand
Clinical Trials on SoundBite Hearing System
-
Sonitus Medical IncCompletedUnilateral Hearing LossUnited States
-
Sonitus Medical IncUnknown
-
Sonitus Medical IncCompletedHearing Loss | Unilateral Hearing Loss | Total Unilateral DeafnessUnited States
-
SoundBite Medical Solutions, Inc.RecruitingChronic Total Occlusion of Artery of the ExtremitiesUnited States, Austria, Germany
-
SoundBite Medical Solutions, Inc.ethica Clinical Research Inc.; Prairie Vascular Research Inc.CompletedChronic Total Occlusion of Arteries of the ExtremitiesUnited States, Canada
-
SoundBite Medical Solutions, Inc.Montreal Heart Institute; ethica Clinical Research Inc.WithdrawnPeripheral Arterial Occlusive Disease | Chronic Total Occlusion of Artery of the ExtremitiesAustria, Germany
-
SoundBite Medical Solutions, Inc.ethica Clinical Research Inc.; Cardiovascular Research Foundation, New YorkTerminatedChronic Total Occlusion of Coronary ArteryUnited States, Canada
-
University of BernKrebsforschung Schweiz, Bern, SwitzerlandActive, not recruitingHearing Loss | Childhood CancerSwitzerland
-
Envoy Medical CorporationCompleted
-
Northwestern UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed